Your browser is no longer supported. Please, upgrade your browser.
Settings
NVO Novo Nordisk A/S daily Stock Chart
NVO [NYSE]
Novo Nordisk A/S
Index- P/E23.06 EPS (ttm)2.02 Insider Own- Shs Outstand2.08B Perf Week-15.40%
Market Cap97.07B Forward P/E19.01 EPS next Y2.45 Insider Trans- Shs Float1.42B Perf Month-14.94%
Income5.21B PEG2.01 EPS next Q- Inst Own10.20% Short Float0.43% Perf Quarter-15.19%
Sales16.13B P/S6.02 EPS this Y34.00% Inst Trans-0.34% Short Ratio4.76 Perf Half Y-19.76%
Book/sh2.74 P/B17.00 EPS next Y8.41% ROA41.50% Target Price60.10 Perf Year12.46%
Cash/sh1.46 P/C31.88 EPS next 5Y11.50% ROE86.40% 52W Range41.22 - 60.34 Perf YTD-19.80%
Dividend0.73 P/FCF34.38 EPS past 5Y22.50% ROI85.00% 52W High-22.80% Beta0.83
Dividend %1.57% Quick Ratio1.00 Sales past 5Y12.20% Gross Margin85.00% 52W Low12.99% ATR1.56
Employees40261 Current Ratio1.30 Sales Q/Q17.50% Oper. Margin45.60% RSI (14)23.37 Volatility2.84% 2.21%
OptionableYes Debt/Eq0.02 EPS Q/Q29.70% Profit Margin32.20% Rel Volume1.54 Prev Close47.02
ShortableYes LT Debt/Eq0.00 EarningsFeb 03 BMO Payout38.60% Avg Volume1.29M Price46.58
Recom1.00 SMA20-13.01% SMA50-16.00% SMA200-16.66% Volume1,976,807 Change-0.94%
Aug-28-15Initiated Leerink Partners Mkt Perform $56
Jun-09-15Upgrade Morgan Stanley Equal-Weight → Overweight
Apr-15-15Initiated Societe Generale Sell
May-28-13Upgrade Deutsche Bank Sell → Hold
Mar-31-10Initiated Deutsche Bank Hold
Mar-30-10Downgrade Mehta Partners Outperform → Market Perform
Feb-24-10Upgrade Jefferies & Co Hold → Buy
Jan-15-10Downgrade Jefferies & Co Buy → Hold
Sep-11-09Initiated Jefferies & Co Buy
Aug-07-09Downgrade UBS Buy → Neutral
Aug-07-09Downgrade JP Morgan Overweight → Neutral
May-12-09Initiated Piper Jaffray Buy
Apr-24-09Upgrade Citigroup Hold → Buy
Mar-26-09Upgrade UBS Neutral → Buy
Jan-14-09Downgrade Citigroup Hold → Sell
Oct-06-08Upgrade Deutsche Securities Hold → Buy
Aug-29-08Downgrade Bernstein Mkt Perform → Underperform
Aug-21-08Initiated UBS Neutral
Jun-09-08Upgrade HSBC Securities Underweight → Neutral
Feb-26-08Downgrade Bear Stearns Outperform → Peer Perform
Feb-09-16 08:25AM  Analyzing the Price Movement -- Analyst Research on Goldcorp, Questar, Dollar General and Novo Nordisk Accesswire
Feb-08-16 05:20PM  How Novos Diabetes and Obesity Care Segment Performed in 4Q15
05:08PM  Why Novo Nordisk Fell after Its 4Q15 Earnings Release
09:10AM  Morning Movers: AstraZeneca, Ralph Lauren Drop on Downgrades; Kinross Gold Jumps at Barrons.com
Feb-05-16 11:44AM  Novo Nordisk A/S Earnings Analysis: 2015 By the Numbers
Feb-04-16 04:15PM  Novo Nordisk A/S Taps the Growth Brakes at Motley Fool
01:40PM  Novo Nordisk Posts In Line Q4 Earnings, Tops Revenues
08:07AM  Valeant Pharmaceuticals: The Near-Term Growth Prospects
Feb-03-16 06:35AM  European Stocks Fall as Asia Declines, Earnings Disappoint at TheStreet -6.10%
06:27AM  [$$] Novo Nordisk lowers earnings targets as drug price pressure grows at Financial Times
05:13AM  Novo Nordisk CEO Sees Limited Scope for U.S. Price Increases at Bloomberg
04:53AM  [$$] Novo Nordisk Shares Plunge on Profit Growth Forecast at The Wall Street Journal
04:45AM  Drugmaker Novo surprises with long-term profit target cut
04:39AM  Novo Nordisk CEO: Optimism on Increased U.S. Access
03:18AM  More Losses for Europe Stocks as Banks Fall, Earnings Disappoint at Bloomberg
01:40AM  Novo Nordisk Quarterly Profit Misses Estimates on Victoza at Bloomberg
Jan-30-16 03:15PM  Chinas diabetes boom promises $23 billion pot for drug makers at MarketWatch
Jan-29-16 08:51AM  Tresiba® demonstrates significantly lower rate of hypoglycaemia than insulin glargine in blinded phase 3b trial in people with type 2 diabetes at noodls
Jan-26-16 07:33AM  How Recent Events Could Affect Novo Nordisks Earnings
Jan-25-16 03:58PM  Stock Picks Worked Well for VGEAX in 2015
11:57AM  Novo Nordisk A/S - aktietilbagekøbsprogram at noodls
07:47AM  Novo Nordisk A/S - Share repurchase programme at noodls
Jan-19-16 09:14AM  Slow Global Growth: Is the Magic of Emerging Markets Over?
Jan-18-16 02:06PM  How Is Novo Nordisks Position in the Diabetes Segment?
02:04PM  What to Expect from Novo Nordisks 4Q15 Earnings
Jan-15-16 11:52AM  Can Twitter Save MannKind Corporation? at Motley Fool
Jan-08-16 08:03AM  Why Novo Nordisk A/S Shares Jumped 40% in 2015 at Motley Fool
Jan-06-16 12:31PM  This Just In: Is This Analyst Wrong About the Future of MannKind? at Motley Fool
04:25AM  Drugs Join Danish Design, Degustation as Hot Commodities: Chart at Bloomberg
04:25AM  Drugs Join Danish Design, Degustation as Hot Commodities: Chart
Dec-30-15 04:47PM  The 5 Top-Performing Big-Cap Drug Stocks Of 2015 at Investor's Business Daily
09:58AM  National Oilwell Varco: There Goes a Big Chunk of Backlog at Barrons.com
Dec-23-15 05:04PM  Unique Positioning Has Helped VGEAX So Far in 2015
10:51AM  Job hunting this New Year's? The top North Carolina job announcements in 2015 at bizjournals.com
10:16AM  Danish Krone Rose amid the Falling GDP Growth
Dec-22-15 12:30PM  Eli Lilly's New 'Breakthrough': Infinitesimal Innovation at Forbes
06:25AM  Swedish Krona Rose as Economic Confidence Improved
Dec-21-15 08:32AM  Traders bet on gains in Novo Nordisk
Dec-19-15 11:00PM  Look for Companies with a moat
Dec-15-15 05:42PM  Jim Simons' Top Holdings Include VeriSign, Chipotle
11:41AM  Does Novo Nordisk's New Diabetes Drug Spell Doom for MannKind Corp? at Motley Fool
Dec-10-15 04:35PM  Novo Nordisk Files Faster-Acting Insulin Aspart NDA in U.S.
04:30PM  Novo Nordisk partners with IBM Watson Health to develop diabetes management tools at bizjournals.com
Dec-08-15 08:00AM  Why Biotech Affimed N.V. Should Be On Your Radar at Investopedia
Dec-07-15 04:25PM  Eli Lilly Halts Development of Basal Insulin Peglispro
Dec-03-15 09:45AM  APNewsBreak: Novo Nordisk got $130M offer for NC drug plant
Dec-02-15 05:05PM  XOMA Inks Agreement with Novo Nordisk for XMetA Program
Dec-01-15 01:00PM  Xoma Stock Surges, Sells Diabetes Treatment to Novo Nordisk for $295 Million at TheStreet
01:00PM  While obesity rates differ among ethnic groups; data shows similar weight loss results using Saxenda®(1),(2) CNW Group
09:29AM  Stocks to Watch: Amazon, Mattress Firm, Johnson Controls at The Wall Street Journal
09:23AM  [$$] Novo Nordisk Buys Xoma's Diabetes Treatment at The Wall Street Journal
Nov-30-15 04:48PM  Is Novo Nordisk A/S (ADR) (NVO) Going to Burn These Hedge Funds? at Insider Monkey
Nov-25-15 01:10PM  Novartis Gets EU Approval for Cardiovascular Drug Entresto
09:30AM  The Zacks Analyst Blog Highlights: Amphastar Pharmaceuticals, Mylan, Pernix Therapeutics Holdings, Eli Lilly and Novo Nordisk
Nov-24-15 04:32PM  Do Hedge Funds Love Comcast Corporation (CMCSK)? at Insider Monkey
12:09PM  Forget Allergan & Pfizer, Buy These Drug Stocks Instead
08:55AM  Back To The Future The Bull Rumbles Forward at Forbes
Nov-20-15 02:10PM  Like Ranges? These Are Stocks to Consider at Investopedia
12:50PM  Valeant to Up Incentives to Retain Key Employees Amid Turmoil
Nov-18-15 04:13PM  Novartis Announces Positive Results on Ultibro Breezhaler
09:10AM  Jefferies Reveals Top 5 Pharma Stock Picks for Growth and Dividends at 24/7 Wall St.
Nov-17-15 05:36PM  Mallinckrodt Gets FDA Nod for Inomax DS Plus MRI Device
04:50PM  Analysis of International Mutual Funds: Investor Takeaways
Nov-16-15 05:05PM  Roche's Lung Cancer Diagnostic Test Approved in the U.S.
Nov-15-15 11:15AM  Novo Nordisk shrugs off diabetes drugs gloom at Financial Times
Nov-14-15 01:19PM  Multi-Billion-Dollar Fund Renaissance Technologies Entered Q4 With These Top Picks at Insider Monkey
03:01AM  Very Little To Celebrate On World Diabetes Day at Forbes
Nov-11-15 01:11PM  Arrowstreet Capital Goes Heavily Bullish & Bets Big on These Stocks in Q4 at Insider Monkey
11:40AM  Danish Krone Fell and Inflation Was below the Forecasts
Nov-09-15 11:40AM  Novo Nordisk A/S Earnings Q3, 2015
Nov-08-15 03:45PM  Novo Nordisk diabetes drug fails to help heart failure -study
Nov-03-15 01:00PM  Billionaire Ken Fishers Top Healthcare Stock Picks at Insider Monkey
Nov-02-15 05:40PM  Novo Nordisk A/S Earnings: Benefiting From a Stronger Dollar at Motley Fool
Nov-01-15 09:41AM  These Drugs Could Deliver $5 Billion (or More) in Annual Sales at Motley Fool
Oct-30-15 11:17AM  Novo Nordisk (NVO) Beats on Q3 Earnings, Maintains View
Oct-29-15 12:40PM  Sanofi, Novo Nordisk Slide On Diabetes Headwinds at Investor's Business Daily -6.70%
09:04AM  [$$] Novo Nordisk Profit Jumps 29% but Earnings Growth Likely to Slow at The Wall Street Journal
08:29AM  Novo Nordisk Profit Beat Estimates
02:41AM  Novo Nordisk Profit Beats Estimates as Insulin Sales Climbed at Bloomberg
Oct-28-15 03:37PM  The JPMorgan Intrepid European Fund Class A (VEUAX): Historical Overview
Oct-26-15 11:07AM  Pfizers 3Q15 Earnings: Products Expected to Offset Growth
09:07AM  Pfizers 3Q15 Earnings: Expected Growth Contributors
Oct-22-15 04:30PM  Novo Nordisk Expands License Agreement with Emisphere
Oct-21-15 12:16PM  Abbott (ABT) Posts Higher-Than-Expected Q3 Earnings
Oct-16-15 02:16PM  New Deal Between Emisphere Technologies Inc. (EMIS) and Novo Nordisk A/S (ADR) (NVO) at Insider Monkey
Oct-15-15 04:40PM  Pfizer's Oral Formulation of Xeljanz Gets CRL from the FDA
08:21AM  Emisphere Signs License Agreement With Novo Nordisk to Develop Oral Formulations of Four Molecules Targeting Metabolic Indications and Amends GLP-1 Agreement GlobeNewswire
Oct-14-15 03:55PM  Abbott Labs Releases Data on Dissolving Heart Stent Absorb
Oct-13-15 07:00PM  Cramer: Why now is NOT the time to buy
04:35PM  How RTP factors in the Harvard Business Review's list of top CEOs at bizjournals.com
Oct-12-15 05:02PM  Warren Buffett Not Top 100 CEO; Ex VW CEO Is No. 20 at Investor's Business Daily
Oct-08-15 10:32AM  Not Even Jim Simons Mathematical Models Could Pick Winning Stocks In Q3 at Insider Monkey
Oct-01-15 05:46PM  Celsion Begins Patient Enrollment in Ovarian Cancer Study
10:00AM  Xybion announces that Novo Nordisk selects Pristima to manage pharmacology research studies across all research sites PR Newswire
Sep-30-15 05:38PM  Why Novo Nordisk Is All in on New Diabetes Drug at TheStreet
05:35PM  Roche Presents Positive Data on Respiratory Drug Esbriet
03:49PM  Novo Nordisk Betting on New Long-Lasting Diabetes Drug to Dominate at TheStreet
Sep-28-15 04:30PM  Novo Nordisk's Tresiba & Ryzodeg Gain Entry into the U.S.
11:58AM  This is What Hedge Funds Have to Say about Two Healthcare Stocks on the Move at Insider Monkey
08:50AM  Is Novo Nordisk (NVO) Stock a Solid Choice Right Now?
Novo Nordisk A/S, a healthcare company, engages in the discovery, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes Care and Biopharmaceuticals. The Diabetes Care segment covers insulins, GLP-1 analog, obesity, and oral antidiabetic drugs, as well as other protein related products comprising glucagon, protein related delivery systems, and needles. The Biopharmaceuticals segment offers products in the areas of haemophilia care, growth hormone therapy, and hormone replacement therapy. The company markets and distributes its products through its subsidiaries, distributors, and independent agents. Novo Nordisk A/S has a collaboration agreement with the Langer Laboratory for the development of next-generation drug delivery devices; and collaboration and licensing agreement with Ablynx nv to discover and develop novel multi-specific Nanobody drug candidates. The company was founded in 1925 and is headquartered in Bagsvaerd, Denmark.